Schwazze Snaps Up Everest Apothecary in New Mexico for $38 Million

April 25, 2023 · Green Market Report

Schwazze will now own 32 dispensaries between Everest Apothecary and R. Greenleaf.

Denver-based Medicine Man Technologies Inc., which operates as Schwazze (OTCQX: SHWZ) (NEO: SHWZ), has signed definitive documents to acquire a batch of cannabis assets in New Mexico.

The acquisition will allow Schwazze to manage Everest Apothecary, a non-profit corporation operating in the state. The proposed transaction includes 14 retail dispensaries, a cultivation facility, and a manufacturing plant.

Upon completion of the acquisition, Schwazze will have a total of 32 dispensaries in New Mexico, with over 450 employees.

The purchase price for the proposed acquisition is $38 million. Schwazze will pay the sum using a combination of cash, a four-year seller note, and company common stock. The acquisition is expected to close in the second quarter of 2023, subject to approval from the New Mexico Regulation and Licensing Department.

“This planned acquisition shows our commitment to the Company’s super-regional cannabis growth strategy to go deep in select markets,” Schwazze president Nirup Krishnamurthy said in a statement.

“The Everest brand is a perfect complement to our existing retail brand in New Mexico. Each serves a unique demographic, and we will continue to operate both retail banners in the state.”

Krishnamurthy added that by utilizing Schwazze’s operating playbook, the company intends to support the Everest team and its customers under the new deal.

Once commonly known as Medicine Man, Schwazze’s aggressive expansion strategy began in April 2020, after the company went public and has since snapped up retail competitors around Colorado and New Mexico, as well as eight cultivation facilities and three manufacturing plants.

The company also recently announced its biosciences division and commenced home delivery services in Colorado. It plans to continue pursuing acquisitions, partnerships, and strategic investments to expand its retail presence and market share.

Schwazze posted an annual $18.5 million loss by the end of 2022, in part due to its acquisitions and entry in New Mexico. Still, the company posted solid increases in revenue, profit, retail sales, and cash flow for both the full year and for the fourth quarter. (Full Story)

Next Post

Here’s what weed tourists from Texas can expect to find inside recreational pot shops

Marijuana is still an illegal substance in Texas. But with neighboring states offering recreational weed, many Texans are crossing state lines to taste the high life. In total, 21 states across the U.S. have legalized recreational marijuana use — Colorado and…
Read
Previous Post

Data Confirms 4/20 is THE High Holiday

Sales on 4/20 were roughly twice the sales of a typical Thursday. Now that 4/20 is officially in the rearview mirror, the bean counters say that this year’s holiday did not disappoint. Consumers clearly don’t care whether cannabis companies are…
Read
Random Post

New Jersey Senators Discuss Top Lawmaker’s Psilocybin Legalization Bill In Committee

A New Jersey Senate committee held a hearing on Monday to discuss a bill that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older while also creating a system of licensed businesses to…
Read
Random Post

3 Things About Trulieve Cannabis That Smart Investors Know

Given the general bearishness in the cannabis industry, Trulieve has something to offer to investors with high risk-appetites. After a rollercoaster ride over the last few years, the marijuana industry no longer seems enticing to investors. The lack of progress…
Read
Random Post

The Battle to Legalize Weed in Europe - Which Countries are Pro-Cannabis and Which Countries are Pushing Back?

The momentum for legalizing cannabis is building up throughout Europe. There is now an increasing number of countries looking to follow in the footsteps of Canada and some parts of the U.S. by approving cannabis use. During the Cannabis Europa industry event…
Read
Random Post

New York Judge Narrows Scope of Dispensary Licensing Injunction

A New York Appeals Court judge on Tuesday narrowed the preliminary injunction on the state’s conditional adult-use retail dispensary (CAURD) plan to only include the state’s Finger Lakes region. The lawsuit, by Michigan-based Variscite NY One, had affected 63 of the 150…
Read